| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0097 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |